Present state of knowledge of the upper atmosphere 1988: An assessment report

This document was issued in response to the Clean Air Act Amendments of 1977, Public Law 95-95, mandating that NASA and other key agencies submit biennial reports to Congress and EPA. NASA is to report on the state of our knowledge of the upper atmosphere, particularly the stratosphere. This is the sixth ozone assessment report submitted to Congress and the concerned regulatory agencies. Part 1 contains an outline of the NASA Upper Atmosphere Research Program and summaries of the research efforts supported during the last two years. An assessment is presented of the state of knowledge as of March 15, 1988 when the Ozone Trends Panel, organized by NASA and co-sponsored by the World Meteorological Organization, NOAA, FAA and the United Nations Environment Program released an executive summary of its findings from a critical in-depth study involving over 100 scientists from 12 countries. Chapter summaries of the International Ozone Trends Panel Report form the major part of this report. Two other sections are Model Predictions of Future Ozone Change and Chemical Kinetics and Photochemical Data for Use in Stratospheric Modeling. Each of these sections and the report in its entirety were peer reviewed

A Response to the IPCC Fifth Assessment

The Intergovernmental Panel on Climate Change\u27s (IPCC) Fifth Assessment Report presented significant data and findings about climate change. But the IPCC\u27s working groups\u27 summaries for policymakers avoid making normative statements about the IPCC\u27s findings. The authors, members of the Environmental Law Collaborative, bridge this gap by identifying the normative claims that stem from the working groups\u27 summaries to spark deeper discussion and help shape the IPCC\u27s sixth assessment

Clinical trials with endothelin receptor antagonists: What went wrong and where can we improve?

In the early 1990s, within three years of cloning of endothelin receptors, orally active endothelin receptor antagonists (ERAs) were tested in humans and the first clinical trial of ERA therapy in humans was published in 1995. ERAs were subsequently tested in clinical trials involving heart failure, pulmonary arterial hypertension, resistant arterial hypertension, stroke/subarachnoid hemorrhage and various forms of cancer. The results of most of these trials – except those for pulmonary arterial hypertension and scleroderma-related digital ulcers – were either negative or neutral. Problems with study design, patient selection, drug toxicity, and drug dosing have been used to explain or excuse failures. Currently, a number of pharmaceutical companies who had developed ERAs as drug candidates have discontinued clinical trials or further drug development. Given the problems with using ERAs in clinical medicine, at the Twelfth International Conference on Endothelin in Cambridge, UK, a panel discussion was held by clinicians actively involved in clinical development of ERA therapy in renal disease, systemic and pulmonary arterial hypertension, heart failure, and cancer. This article provides summaries from the panel discussion as well as personal perspectives of the panelists on how to proceed with further clinical testing of ERAs and guidance for researchers and decision makers in clinical drug development on where future research efforts might best be focused

Workshop in OCL and Textual Textual Modelling: Report on Recent Trends and Panel Discussion

This paper reports on the panel session of the 17th Workshop in OCL and Textual Modeling, As in previous years, the panel session featured several lightning talks for presenting recent developments and open questions in the area of OCL and textual modeling. During this session, the OCL community discussed, stimulated through short pre- sentations by OCL experts, proposals for improving OCL to increase the attractiveness of textual modeling. This paper contains a summary of the workshop from the workshop organisers as well as summaries of two lightning talks provided by their presenters

Space Station Technology, 1983

This publication is a compilation of the panel summaries presented in the following areas: systems/operations technology; crew and life support; EVA; crew and life support: ECLSS; attitude, control, and stabilization; human capabilities; auxillary propulsion; fluid management; communications; structures and mechanisms; data management; power; and thermal control. The objective of the workshop was to aid the Space Station Technology Steering Committee in defining and implementing a technology development program to support the establishment of a permanent human presence in space. This compilation will provide the participants and their organizations with the information presented at this workshop in a referenceable format. This information will establish a stepping stone for users of space station technology to develop new technology and plan future tasks

Estimating the burden of minor ailment consultations in general practices and emergency departments through retrospective review of routine data in North East Scotland

Minor ailment attendances in general practices and emergency departments (EDs) place significant burden on health care resources